Skip to content

Canopy News

Featured

Press Release
Clinical

Canopy Studies Selected for Oral and Poster Presentations at 2026 ASCO Annual Meeting

New data demonstrate the potential of the Canopy Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing hospitalizations and increasing time on treatment. Canopy, the leader in Enterprise AI for oncology, today announced two abstracts selected for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies demonstrate the potential of the Canopy RTM Platform to improve outcomes during systemic outpatient care.

Read more

Articles

Canopy Named to the New York Digital Health 100 for Third Consecutive Year
Clinical

Canopy Named to the New York Digital Health 100 for Third Consecutive Year

Canopy, the leader in Enterprise AI for oncology, announced today that it has been named to the 2026 New York Digital Health 100 (DH100) for the third consecutive year, an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Canopy helps cancer centers manage the growing complexity of care by providing an Enterprise AI platform across patient services: triage, call center, front office, referrals, and pharmacy. By embedding AI and automation into existing workflows, Canopy enables faster issue resolution for patients, reduces manual work for staff, and helps practices capture sustainable reimbursement for this care.

Read more
WVCI
Clinical

USA Health Partners with Canopy to Operationalize AI-powered Care and Remote Therapeutic Monitoring in Academic Oncology Care

Canopy, the leader in Enterprise AI for oncology, today announced a partnership with the University of South Alabama (USA) Health Mitchell Cancer Institute, an academic research and treatment facility in Mobile, Alabama, to transform patient support between visits. USA Health selected Canopy’s AI-native platform to replace legacy systems, aiming to extend the benefits of Remote Therapeutic Monitoring (RTM) across increasingly complex therapies while reducing operational burden for staff.

Read more
WVCI
Clinical

Utah Cancer Specialists Partners with Canopy for Remote Therapeutic Monitoring and Enterprise AI

Canopy, the leader in Enterprise AI for oncology, today announced a partnership with Utah Cancer Specialists (UCS), the largest community-based oncology and hematology practice in Utah and a member of the ONCare Alliance, to modernize how care teams support patients between visits. UCS selected Canopy to replace legacy systems with an AI-native solution that keeps pace with the needs of their patients and staff while building scalable programs for Remote Therapeutic Monitoring (RTM) and Care Management (CCM/PCM).

Read more
Press Release
Clinical

Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients

New data demonstrate the potential of Canopy's Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing serious infections in patients with hematologic malignancies, resulting in an estimated $977,695 in annual savings per 1,000 patients. Canopy, the leader in Enterprise AI for oncology, today announced new findings that highlight how its RTM Platform strengthens outpatient care and reduces infection-related escalations in patients with hematological malignancies.

Read more

Media Coverage